Metavasi Capital’s Xometry XMTR Stock Holding History

Metavasi Capital’s Portfolio XMTR Stock Details XMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-125,000	Closed	-$5.11M	–	33
2026 Q1	$5.11M	Buy	125,000 +55,000	+79%	+$2.92M	1.85%	16
2025 Q4	$4.16M	Buy	+70,000	New	+$3.95M	1.7%	25
2025 Q3	–	Sell	-43,597	Closed	-$1.47M	–	45
2025 Q2	$1.47M	Buy	+43,597	New	+$1.28M	0.6%	30

Other funds holding XMTR

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Metavasi Capital's XMTR Position: Q2 2026 in Review

Metavasi Capital sold out of Xometry (XMTR) in Q2 2026, closing a stake of 125,000 shares — an estimated $5.11M sold.

Metavasi Capital first reported a position in XMTR in Q2 2025 and held it in 3 quarters. The position peaked at $5.11M in Q1 2026. 293 funds tracked by Wall St. Rank hold XMTR as of Q2 2026.

Metavasi Capital reported no remaining Xometry position as of Q2 2026 after selling out during the quarter.
Metavasi Capital sold 125,000 Xometry shares in Q2 2026, an estimated $5.11M.
Metavasi Capital first reported a position in Xometry in Q2 2025 and held it in 3 quarters.
Metavasi Capital's Xometry position peaked at $5.11M in Q1 2026.
293 funds tracked by Wall St. Rank held Xometry as of Q2 2026.

Based on Metavasi Capital's 13F filing for Q2 2026, filed 14 Aug 2026.